Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin. (Q46691035)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18355328%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18355328%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18355328%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

R C T Mori

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18355328%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

A E Hirata

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18355328%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

M M Okamoto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18355328%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

U F Machado

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18355328%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

18 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18355328%20AND%20SRC:MED&resulttype=core&format=json

Diabetes, Obesity and Metabolism

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18355328%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18355328%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18355328%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

596-600

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18355328%20AND%20SRC:MED&resulttype=core&format=json

GLUT4 protein is differently modulated during development of obesity in monosodium glutamate-treated mice

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00870.X

Participation of beta-adrenergic activity in modulation of GLUT4 expression during fasting and refeeding in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00870.X

Insulin resistance in soleus muscle from obese Zucker rats. Involvement of several defective sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00870.X

Extrapancreatic effects of sulfonylurea drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00870.X

Glimepiride reduces mononuclear activation of the redox-sensitive transcription factor nuclear factor-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00870.X

NF-kappaB, MEF2A, MEF2D and HIF1-a involvement on insulin- and contraction-induced regulation of GLUT4 gene expression in soleus muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00870.X

10.1111/J.1463-1326.2008.00870.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18355328%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference